Accendra Health, Inc. ACH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -13.69% | -10.07% | -6.84% | 2.01% | 1.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.69% | -10.07% | -6.84% | 2.01% | 1.52% |
| Cost of Revenue | -9.22% | -2.10% | -1.38% | 6.54% | 5.63% |
| Gross Profit | -18.90% | -18.85% | -12.91% | -2.92% | -2.89% |
| SG&A Expenses | -6.16% | -9.07% | -2.72% | 1.22% | -2.38% |
| Depreciation & Amortization | -82.98% | 288.79% | 292.02% | 267.98% | 249.84% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.23% | -1.59% | 1.56% | 7.54% | 5.41% |
| Operating Income | -74.68% | -119.06% | -113.01% | -62.23% | -46.90% |
| Income Before Tax | -912.90% | -3.15% | -200.96% | 97.36% | -479.44% |
| Income Tax Expenses | -1,056.29% | 227.95% | -515.74% | -95.06% | 750.83% |
| Earnings from Continuing Operations | -220.33% | -6.26% | -69.76% | 97.15% | -544.65% |
| Earnings from Discontinued Operations | 98.80% | -- | -- | -231.16% | -931.07% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 86.89% | 89.75% | 74.11% | 80.98% | -1,076.79% |
| EBIT | -74.68% | -119.06% | -113.01% | -62.23% | -46.90% |
| EBITDA | -49.81% | -38.93% | -40.08% | -66.16% | -19.06% |
| EPS Basic | 86.83% | 89.72% | 73.83% | 80.86% | -1,073.45% |
| Normalized Basic EPS | -954.77% | -1,220.99% | -266.02% | -- | -114.18% |
| EPS Diluted | 86.83% | 89.72% | 73.89% | 80.74% | -1,073.45% |
| Normalized Diluted EPS | -954.77% | -1,220.99% | -266.02% | -- | -114.43% |
| Average Basic Shares Outstanding | -0.49% | -0.31% | -1.09% | -0.61% | 0.26% |
| Average Diluted Shares Outstanding | -0.49% | -0.31% | -1.09% | -0.61% | -1.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |